Mutations in the SCN1A gene, encoding the neuronal voltage-gated sodium channel 1 subunit, cause SMEI, GEFS+, and related epileptic syndromes. We herein report the R1575C-SCN1A mutation identified in a patient with Rasmussen encephalitis. R1575C
Introduction
Rasmussen encephalitis (RE) is an autoimmune-mediated brain disorder associated with intractable focal epilepsy, slowly progressive neurological deterioration and progressive unilateral hemispheric atrophy (Rasmussen et al., 1958) . Serum samples of patients with RE contain antibodies to glutamate receptor GluR3, and immunization of animals with GluR3 induces a disorder resembling the human disease (Roger et al., 1994) . Histopathological studies have shown an infiltration of T lymphocytes and microglia cells, astrocytosis and neuronal loss. A viral infection, humoral autoimmunity and T-cell mediated cytotoxicity have been postulated as the possible mechanisms of RE (Bien et al, 2005) . Although the pathogenesis of RE has not yet been completely elucidated, it is widely accepted that environmental factors largely contribute to RE.
In contrast to RE, the inherited form of epilepsy is caused by genetic factors.
Generalized epilepsy with febrile seizures plus (GEFS+) is a familial epilepsy syndrome characterized by heterogeneous phenotypes, including febrile seizures, febrile seizures plus, and mild to severe epilepsies (Scheffer and Berkovic., 1997) . The SCN1A gene, which encodes the neuronal voltage-gated sodium channel 1 subunit, has been identified in patients with GEFS+, severe myoclonic epilepsy of infancy (SMEI, or Dravet syndrome) and related epileptic syndromes. Other undiscovered modifier genes Rasmussen syndrome with SCN1A mutation, Ohmori et al. 5 and environmental factors may lead to the wide spectrum of SCN1A-associated epilepsies.
We herein report the SCN1A-R1575C mutation identified in a patient with Rasmussen encephalitis. We found this mutation fortuitously in the process of the SCN1A mutational screening of 98 patients having various types of epileptic syndromes.
The R1575C mutant channels transiently expressed in human embryonic kidney (HEK) 293 cells exhibited defects of the electrophysiological properties. Since de novo mutations of the SCN1A gene have been reported in patients with alleged vaccine encephalopathy (Berkovic et al., 2006) , we should carefully assess this new aspect of genetic-environmental interaction in an autoimmune-mediated brain disorder.
Materials and Methods

Patient A
The patient was a 10-year-old girl and her representative clinical data are shown in The study was approved by the Ethics Committee of Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences. Written informed consent was obtained from the parents.
Mutagenesis and heterologous expression of SCN1A
Mutagenesis of full-length human SCN1A cDNA was performed as described previously (Lossin et al., 2002) . In all of the experiments, recombinant SCN1A was heterologously coexpressed with the human β1 and β2 accessory subunits in the HEK293 cells.
Electrophysiology and data analysis
Whole-cell voltage-clamp recordings were used to characterize the functional properties of the wild type (WT)-SCN1A and R1575C mutant sodium channel, as described previously (Ohmori et al., 2006) . Sodium channel currents were recorded at room temperature, 24-72 h after transfection. Patch pipettes were pulled (1. 
Results
SCN1A mutational analysis
The novel R1575C mutation was identified in patient A and her unaffected father ( Fig. 1E ). No other family members agreed to undergo any genetic tests. We did not find the R1575C mutation in the healthy individuals (n = 96).
Electrophysiological properties
We examined the R1575C mutation for functional defects by using a heterologous expression system. Fig. 2A illustrates the representative whole-cell currents recorded from the HEK293 cells expressing WT-SCN1A, or R1575C. Cells expressing the R1575C mutant exhibited a voltage-dependent inward current which resembled the cells transfected with WT channels. The inactivation proceeded in a rapid biexponential manner, with no apparent difference between WT and R1575C (Fig. 2B) . However, the Rasmussen syndrome with SCN1A mutation, Ohmori et al. 10 presence of a persistent sodium current in R1575C was observed. Fig. 2C illustrates the representative tetrodotoxin (TTX)-subtracted current traces for both WT-SCN1A and R1575C in response to a 100-ms voltage step to−10 mV from a holding potential of −120 mV. The cells expressing R1575C exhibited a significantly greater persistent current which was expressed as percentage of the peak current in comparison to WT-SCN1A (Fig. 2D) .
The current density, voltage-dependence channel activation, inactivation and recovery from fast inactivation were examined (Fig. 3 ). R1575C showed no difference for the current density, voltage-dependence channel activation and recovery from fast inactivation in comparison to WT. R1575C displayed the most significant defect in fast inactivation. R1575C exhibited a slight depolarizing shift in half-maximal steady-state inactivation (Fig. 3C ).
Discussion
The early clinical features of febrile and afebrile convulsions and family history are The R1575C-SCN1A mutation in patient A was carried by her unaffected father.
However, it was not detected in healthy individuals (n = 96). An electrophysiological study showed that the R1575C channels had increased channel availability and increased persistent sodium current, which can lead to neuronal hyperexcitability.
Increased persistent current is a common functional abnormality in SCN1A-associated epileptic syndromes (Lossin et al., 2002 , Ohmori et al., 2006 . Taken together, these findings therefore suggest that R1575C may be a seizure susceptibility allele. The seizure susceptibility allele may influence the pathogenesis of Rasmussen encephalitis.
The spectrum of SCN1A-associated brain disorders has been expanding. The mildest form is simple febrile seizure and the most severe form is SMEI. SCN1A mutations have also been identified in familial hemiplegic migraines (C) Representative tetrodotoxin-subtracted whole-cell sodium currents recorded from HEK293 cells expressing WT-SCN1A or R1575C. Each current trace has been normalized to its peak sodium current. (D) Average persistent sodium current expressed as a percentage of the peak current for WT-SCN1A (0.38% ± 0.10%; n = 7) and R1575C (2.12% ± 0.68%; n = 7; p = 0.027). R1575C exhibited a significantly increased persistent current in comparison to WT-SCN1A (p < 0.05). Current density of R1575C is similar to WT-SCN1A. (B) Voltage dependence of channel activation measured during voltage steps to between −80 and +20 mV from a holding potential of −120 mV. Half-maximal activation occurred at -25.9±1.5 mV with a slope factor of -6.2 ± 0.3 (n=17) for WT-SCN1A and at -24.6 ± 1.1 mV with a slope factor of -6.2 ± 0.2 (n=12) for R1575C. (C) Voltage dependence of fast inactivation measured at −10 mV in response to a 100-ms prepulse voltage step to between −140 and −10 mV from a holding potential of −120 mV. The membrane potentials for half-maximal inactivation and slope factors were as follows: WT, -62.1 ± 1.3 mV and -5.8 ± 0.2, n=15; R1575C, -58.5 ± 1.0 mV (p=0.043) and -6.2 ± 0.3, n=12. (D) Time-dependent recovery from fast inactivation measured at −10 mV between 1 and 3,000 ms immediately after a 100-ms prepulse voltage step to −10mV from a holding potential of −120 mV. The time constants and fractional amplitudes were as follows:
WT, f =1.8 ± 0.1 ms (82% ± 1%), s =40.3 ± 5.4 ms (18% ± 1%), n=14; R1575C, f =1.8 ± 0.2 ms (79% ± 2%), s =40.8 ± 4.0 ms (21% ± 2%), n=13. There was no statistically significant difference between WT and R1575C. 
